Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
52
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Colvin Richard A | Chief Medical Officer | 20 | $0 | $28.1K | 2025-06-02 |
| Jones-Burton Charlotte | Director | 10 | $0 | $0 | 2025-06-02 |
| Tita-Reid Najoh | Director | 12 | $0 | $0 | 2025-06-02 |
| Sterling O. James | Chief Financial Officer | 5 | $0 | $0 | 2025-06-02 |
| Leiderman Elisabeth | Director | 13 | $0 | $6.5K | 2025-06-02 |
| Obenshain Andrew | President of SGD | 53 | $0 | $354.2K | 2025-06-02 |
| Paulson Richard A. | Director | 6 | $0 | $0 | 2025-06-02 |
| Cloonan Michael | Director | 3 | $0 | $0 | 2025-06-02 |
| Klima Thomas J | See Remarks | 26 | $0 | $46.0K | 2025-06-02 |
| Agwunobi John O | Director | 25 | $0 | $0 | 2025-06-02 |
| Vachon Mark | Director | 63 | $0 | $4.88M | 2025-06-02 |
| Leschly Nick | President and CEO | 177 | $501.0K | $81.68M | 2025-06-02 |
| Vittiglio Joseph | Chief Business & Legal Officer | 10 | $0 | $6.5K | 2025-06-02 |
| Krawtschuk Christopher | Chief Financial Officer | 4 | $0 | $20.5K | 2024-03-01 |
| Cole Jason | SVP, Secy. & General Counsel | 166 | $0 | $16.03M | 2022-08-19 |
| Eggimann Anne-Virginie | Chief Regulatory Officer | 3 | $0 | $6.7K | 2022-07-12 |
| Whitten Jessica | Chief Accounting Officer | 11 | $0 | $35.1K | 2022-02-01 |
| Consylman Gina | Chief Financial Officer | 4 | $0 | $0 | 2022-02-01 |
| Maus Marcela V. | Director | 4 | $0 | $0 | 2021-11-11 |
| Torres Denice | Director | 8 | $0 | $0 | 2021-11-11 |
| Ibrahim Ramy | Director | 8 | $0 | $0 | 2021-11-11 |
| Sellers William R. | Director | 12 | $0 | $0 | 2021-11-11 |
| Glickman Sarah JS | Director | 4 | $0 | $0 | 2021-11-11 |
| Baird William D III | Chief Financial Officer | 22 | $0 | $231.2K | 2021-11-11 |
| Gregory Philip D | Chief Scientific Officer | 231 | $0 | $10.56M | 2021-11-11 |
| DIXON WENDY L | Director | 25 | $0 | $0 | 2021-11-11 |
| LYNCH DANIEL | Director | 122 | $0 | $8.17M | 2021-11-11 |
| Davidson David | Chief Medical Officer | 392 | $0 | $39.46M | 2021-04-05 |
| Burnett Katy | Principal Accounting Officer | 4 | $0 | $20.3K | 2021-02-17 |
| FINGER ALISON CECILY | Chief Commercial Officer | 32 | $0 | $439.7K | 2021-01-06 |
| Smith-Farrell Joanne | Chief Business Officer | 26 | $0 | $172.8K | 2021-01-06 |
| WENTWORTH KORY JAMES | Principal Accounting Officer | 21 | $0 | $224.5K | 2020-08-03 |
| Schenkein David P | Director | 21 | $100.0K | $677.8K | 2020-06-18 |
| MELTON DOUGLAS | Director | 9 | $0 | $0 | 2020-06-18 |
| Walsh Jeffrey T. | Chief Strategy Officer | 269 | $0 | $45.10M | 2019-08-20 |
| HIGH SUSANNA GATTI | Chief Operating Officer | 35 | $0 | $5.12M | 2018-12-06 |
| Mandell James | Director | 40 | $0 | $2.17M | 2018-09-10 |
| Hedley Mary Lynne | Director | 4 | $0 | $0 | 2018-06-20 |
| MARAGANORE JOHN | Director | 23 | $299.9K | $4.98M | 2017-09-14 |
| Sullivan Eric | VP, Finance & Treasurer | 135 | $0 | $3.03M | 2017-08-04 |
| GILLIS STEVEN | Director | 22 | $0 | $9.30M | 2015-07-28 |
| Finer Mitchell H. | Chief Scientific Officer | 109 | $0 | $23.55M | 2015-06-01 |
| TRV GP, LLC | 10% Owner | 7 | $0 | $13.42M | 2015-02-03 |
| TEPPER ROBERT I | Director, 10% Owner | 26 | $0 | $24.88M | 2015-02-03 |
| DETORE JAMES M. | Chief Financial Officer | 1 | $0 | $0 | 2014-12-01 |
| THIRD ROCK VENTURES LP | 10% Owner | 9 | $0 | $4.57M | 2014-09-12 |
| Bain Linda | VP, Fin. & Business Operations | 24 | $0 | $380.1K | 2014-03-03 |
| Third Rock Ventures GP, L.P. | 10% Owner | 6 | $0 | $6.88M | 2014-01-17 |
| Polack Axel | Director | 20 | $0 | $0 | 2013-06-24 |
| Mulder Geert-Jan | Director | 20 | $0 | $0 | 2013-06-24 |
| Fischer Stefan | 10% Owner | 20 | $0 | $0 | 2013-06-24 |
| BYBEE CLINTON | 10% Owner | 3 | $0 | $0 | 2013-06-24 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Cloonan Michael | Director | D To issuer | 2025-06-02 | 2025-06-03 | 1,867 | — | $0 | 0 | SEC↗ |
| Paulson Richard A. | Director | D To issuer | 2025-06-02 | 2025-06-03 | 1,323 | — | $0 | 0 | SEC↗ |
| Leschly Nick | Director | D To issuer | 2025-06-02 | 2025-06-03 | 1,245 | — | $0 | 0 | SEC↗ |
| Sterling O. James | Chief Financial Officer | D To issuer | 2025-06-02 | 2025-06-03 | 2,500 | — | $0 | 0 | SEC↗ |
| Sterling O. James | Chief Financial Officer | D To issuer | 2025-06-02 | 2025-06-03 | 5,000 | — | $0 | 0 | SEC↗ |
| Sterling O. James | Chief Financial Officer | A Award | 2025-06-02 | 2025-06-03 | 2,500 | — | $0 | 2,500 | SEC↗ |
| Klima Thomas J | See Remarks | D To issuer | 2025-06-02 | 2025-06-03 | 2,500 | — | $0 | 0 | SEC↗ |
| Klima Thomas J | See Remarks | D To issuer | 2025-06-02 | 2025-06-03 | 4,464 | — | $0 | 0 | SEC↗ |
| Klima Thomas J | See Remarks | A Award | 2025-06-02 | 2025-06-03 | 2,500 | — | $0 | 2,500 | SEC↗ |
| Jones-Burton Charlotte | Director | D To issuer | 2025-06-02 | 2025-06-03 | 1,245 | — | $0 | 0 | SEC↗ |
| Leiderman Elisabeth | Director | D To issuer | 2025-06-02 | 2025-06-03 | 1,245 | — | $0 | 0 | SEC↗ |
| Obenshain Andrew | President and CEO | D To issuer | 2025-06-02 | 2025-06-03 | 14,820 | — | $0 | 0 | SEC↗ |
| Obenshain Andrew | President and CEO | A Award | 2025-06-02 | 2025-06-03 | 14,820 | — | $0 | 14,820 | SEC↗ |
| Obenshain Andrew | President and CEO | D To issuer | 2025-06-02 | 2025-06-03 | 9,300 | — | $0 | 0 | SEC↗ |
| Tita-Reid Najoh | Director | D To issuer | 2025-06-02 | 2025-06-03 | 1,245 | — | $0 | 0 | SEC↗ |
| Colvin Richard A | Chief Medical Officer | D To issuer | 2025-06-02 | 2025-06-03 | 2,500 | — | $0 | 0 | SEC↗ |
| Colvin Richard A | Chief Medical Officer | A Award | 2025-06-02 | 2025-06-03 | 2,500 | — | $0 | 2,500 | SEC↗ |
| Colvin Richard A | Chief Medical Officer | D To issuer | 2025-06-02 | 2025-06-03 | 4,166 | — | $0 | 0 | SEC↗ |
| Vachon Mark | Director | D To issuer | 2025-06-02 | 2025-06-03 | 1,245 | — | $0 | 0 | SEC↗ |
| Agwunobi John O | Director | D To issuer | 2025-06-02 | 2025-06-03 | 1,245 | — | $0 | 0 | SEC↗ |
| Vittiglio Joseph | Chief Business & Legal Offic | D To issuer | 2025-06-02 | 2025-06-03 | 2,500 | — | $0 | 0 | SEC↗ |
| Vittiglio Joseph | Chief Business & Legal Offic | D To issuer | 2025-06-02 | 2025-06-03 | 3,125 | — | $0 | 0 | SEC↗ |
| Vittiglio Joseph | Chief Business & Legal Offic | A Award | 2025-06-02 | 2025-06-03 | 2,500 | — | $0 | 2,500 | SEC↗ |
| Paulson Richard A. | Director | U Tender | 2025-05-30 | 2025-06-03 | 155 | — | $0 | 1,323 | SEC↗ |
| Leschly Nick | Director | U Tender | 2025-05-30 | 2025-06-03 | 2,284 | — | $0 | 0 | SEC↗ |
| Leschly Nick | Director | U Tender | 2025-05-30 | 2025-06-03 | 14,416 | — | $0 | 1,245 | SEC↗ |
| Leschly Nick | Director | U Tender | 2025-05-30 | 2025-06-03 | 6,150 | — | $0 | 0 | SEC↗ |
| Klima Thomas J | See Remarks | U Tender | 2025-05-30 | 2025-06-03 | 3,414 | — | $0 | 4,464 | SEC↗ |
| Jones-Burton Charlotte | Director | U Tender | 2025-05-30 | 2025-06-03 | 928 | — | $0 | 1,245 | SEC↗ |
| Leiderman Elisabeth | Director | U Tender | 2025-05-30 | 2025-06-03 | 1,112 | — | $0 | 1,245 | SEC↗ |
| Obenshain Andrew | President and CEO | U Tender | 2025-05-30 | 2025-06-03 | 9,027 | — | $0 | 9,300 | SEC↗ |
| Tita-Reid Najoh | Director | U Tender | 2025-05-30 | 2025-06-03 | 1,163 | — | $0 | 1,245 | SEC↗ |
| Colvin Richard A | Chief Medical Officer | U Tender | 2025-05-30 | 2025-06-03 | 3,552 | — | $0 | 4,166 | SEC↗ |
| Vachon Mark | Director | U Tender | 2025-05-30 | 2025-06-03 | 1,252 | — | $0 | 1,245 | SEC↗ |
| Agwunobi John O | Director | U Tender | 2025-05-30 | 2025-06-03 | 1,323 | — | $0 | 1,245 | SEC↗ |
| Vittiglio Joseph | Chief Business & Legal Offic | U Tender | 2025-05-30 | 2025-06-03 | 1,143 | — | $0 | 3,125 | SEC↗ |
| Obenshain Andrew | President and CEO | S Sale | 2025-03-03 | 2025-03-05 | 921 | $3.92 | $3.6K | 18,327 | SEC↗ |
| Klima Thomas J | See Remarks | S Sale | 2025-03-03 | 2025-03-05 | 500 | $3.92 | $2.0K | 7,878 | SEC↗ |
| Colvin Richard A | Chief Medical Officer | S Sale | 2025-03-03 | 2025-03-05 | 584 | $3.92 | $2.3K | 7,610 | SEC↗ |
| Obenshain Andrew | President and CEO | A Award | 2025-02-10 | 2025-02-12 | 763 | — | $0 | 19,248 | SEC↗ |
| Obenshain Andrew | President and CEO | S Sale | 2025-02-03 | 2025-02-05 | 86 | $7.39 | $636 | 18,485 | SEC↗ |
| Vittiglio Joseph | Chief Business & Legal Offic | S Sale | 2025-02-03 | 2025-02-05 | 238 | $7.39 | $1.8K | 4,501 | SEC↗ |
| Colvin Richard A | Chief Medical Officer | S Sale | 2025-02-03 | 2025-02-05 | 64 | $7.39 | $473 | 8,194 | SEC↗ |
| Klima Thomas J | See Remarks | S Sale | 2025-02-03 | 2025-02-05 | 122 | $7.39 | $902 | 8,378 | SEC↗ |
| Obenshain Andrew | President and CEO | S Sale | 2025-01-06 | 2025-01-08 | 140 | $9.24 | $1.3K | 18,571 | SEC↗ |
| Colvin Richard A | Chief Medical Officer | S Sale | 2025-01-06 | 2025-01-08 | 19 | $9.24 | $176 | 8,257 | SEC↗ |
| Colvin Richard A | Chief Medical Officer | S Sale | 2024-12-10 | 2024-12-12 | 2,824 | $0.42 | $1.2K | 165,544 | SEC↗ |
| Obenshain Andrew | President and CEO | S Sale | 2024-12-10 | 2024-12-12 | 971 | $0.42 | $408 | 374,247 | SEC↗ |
| Vachon Mark | Director | A Award deriv | 2024-11-06 | 2024-11-08 | 49,850 | — | $0 | 49,850 | SEC↗ |
| Leiderman Elisabeth | Director | A Award deriv | 2024-11-06 | 2024-11-08 | 49,850 | — | $0 | 49,850 | SEC↗ |
| Agwunobi John O | Director | A Award deriv | 2024-11-06 | 2024-11-08 | 49,850 | — | $0 | 49,850 | SEC↗ |
| Jones-Burton Charlotte | Director | A Award deriv | 2024-11-06 | 2024-11-08 | 49,850 | — | $0 | 49,850 | SEC↗ |
| Paulson Richard A. | Director | A Award deriv | 2024-11-06 | 2024-11-08 | 49,850 | — | $0 | 49,850 | SEC↗ |
| Leschly Nick | Director | A Award deriv | 2024-11-06 | 2024-11-08 | 49,850 | — | $0 | 49,850 | SEC↗ |
| Tita-Reid Najoh | Director | A Award deriv | 2024-11-06 | 2024-11-08 | 49,850 | — | $0 | 49,850 | SEC↗ |
| Vachon Mark | Director | A Award | 2024-11-06 | 2024-11-08 | 24,900 | — | $0 | 49,941 | SEC↗ |
| Leiderman Elisabeth | Director | A Award | 2024-11-06 | 2024-11-08 | 24,900 | — | $0 | 47,156 | SEC↗ |
| Agwunobi John O | Director | A Award | 2024-11-06 | 2024-11-08 | 24,900 | — | $0 | 51,364 | SEC↗ |
| Jones-Burton Charlotte | Director | A Award | 2024-11-06 | 2024-11-08 | 24,900 | — | $0 | 43,462 | SEC↗ |
| Paulson Richard A. | Director | A Award | 2024-11-06 | 2024-11-08 | 24,900 | — | $0 | 29,563 | SEC↗ |
| Leschly Nick | Director | A Award | 2024-11-06 | 2024-11-08 | 24,900 | — | $0 | 315,839 | SEC↗ |
| Tita-Reid Najoh | Director | A Award | 2024-11-06 | 2024-11-08 | 24,900 | — | $0 | 48,160 | SEC↗ |
| Obenshain Andrew | President and CEO | A Award | 2024-09-30 | 2024-10-02 | 130,000 | — | $0 | 409,998 | SEC↗ |
| Obenshain Andrew | President and CEO | S Sale | 2024-09-30 | 2024-10-02 | 34,780 | $0.53 | $18.4K | 375,218 | SEC↗ |
| Klima Thomas J | See Remarks | S Sale | 2024-09-30 | 2024-10-02 | 1,006 | $0.53 | $533 | 170,000 | SEC↗ |
| Klima Thomas J | See Remarks | A Award | 2024-09-30 | 2024-10-02 | 50,000 | — | $0 | 171,006 | SEC↗ |
| Cloonan Michael | Director | A Award | 2024-09-30 | 2024-10-02 | 37,350 | — | $0 | 37,350 | SEC↗ |
| Sterling O. James | Chief Financial Officer | A Award | 2024-09-30 | 2024-10-02 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Vittiglio Joseph | Chief Business & Legal Offic | A Award | 2024-09-30 | 2024-10-02 | 50,000 | — | $0 | 94,783 | SEC↗ |
| Colvin Richard A | Chief Medical Officer | A Award | 2024-09-30 | 2024-10-02 | 50,000 | — | $0 | 168,368 | SEC↗ |
| Sterling O. James | Chief Financial Officer | A Award deriv | 2024-07-01 | 2024-07-03 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Cloonan Michael | Director | A Award deriv | 2024-06-20 | 2024-06-24 | 74,775 | — | $0 | 74,775 | SEC↗ |
| Klima Thomas J | See Remarks | S Sale | 2024-06-03 | 2024-06-04 | 3,834 | $0.97 | $3.7K | 121,006 | SEC↗ |
| Klima Thomas J | See Remarks | S Sale | 2024-03-04 | 2024-03-05 | 4,573 | $1.53 | $7.0K | 124,840 | SEC↗ |
| Obenshain Andrew | President and CEO | S Sale | 2024-03-04 | 2024-03-05 | 6,095 | $1.53 | $9.3K | 279,998 | SEC↗ |
| Klima Thomas J | See Remarks | A Award deriv | 2024-03-01 | 2024-03-05 | 199,000 | — | $0 | 199,000 | SEC↗ |
| Obenshain Andrew | President and CEO | A Award deriv | 2024-03-01 | 2024-03-05 | 650,000 | — | $0 | 650,000 | SEC↗ |
| Krawtschuk Christopher | Chief Financial Officer | A Award deriv | 2024-03-01 | 2024-03-05 | 199,000 | — | $0 | 199,000 | SEC↗ |
| Vittiglio Joseph | Chief Business & Legal Offic | A Award deriv | 2024-03-01 | 2024-03-05 | 199,000 | — | $0 | 199,000 | SEC↗ |
| Colvin Richard A | Chief Medical Officer | A Award deriv | 2024-03-01 | 2024-03-05 | 199,000 | — | $0 | 199,000 | SEC↗ |
| Colvin Richard A | Chief Medical Officer | S Sale | 2024-03-01 | 2024-03-05 | 6,770 | $1.53 | $10.4K | 118,368 | SEC↗ |
| Obenshain Andrew | President and CEO | S Sale | 2024-02-05 | 2024-02-06 | 1,879 | $0.90 | $1.7K | 286,093 | SEC↗ |
| Vittiglio Joseph | Chief Business & Legal Offic | S Sale | 2024-02-05 | 2024-02-06 | 5,217 | $0.90 | $4.7K | 44,783 | SEC↗ |
| Klima Thomas J | See Remarks | S Sale | 2024-02-05 | 2024-02-06 | 2,714 | $0.90 | $2.4K | 129,413 | SEC↗ |
| Colvin Richard A | Chief Medical Officer | S Sale | 2024-01-05 | 2024-01-09 | 597 | $1.42 | $848 | 125,138 | SEC↗ |
| Obenshain Andrew | President and CEO | S Sale | 2024-01-05 | 2024-01-09 | 3,162 | $1.43 | $4.5K | 287,972 | SEC↗ |
| Krawtschuk Christopher | Chief Financial Officer | S Sale | 2023-12-06 | 2023-12-08 | 4,526 | $4.52 | $20.5K | 45,474 | SEC↗ |
| Obenshain Andrew | President and CEO | S Sale | 2023-11-03 | 2023-11-03 | 807 | $3.17 | $2.6K | 291,134 | SEC↗ |
| Colvin Richard A | Chief Medical Officer | S Sale | 2023-11-02 | 2023-11-03 | 2,343 | $2.98 | $7.0K | 125,735 | SEC↗ |
| Klima Thomas J | See Remarks | S Sale | 2023-09-05 | 2023-09-06 | 922 | $3.79 | $3.5K | 132,127 | SEC↗ |
| Obenshain Andrew | President and CEO | S Sale | 2023-08-10 | 2023-08-10 | 16,929 | $3.54 | $59.9K | 291,941 | SEC↗ |
| Jones-Burton Charlotte | Director | A Award deriv | 2023-06-16 | 2023-06-20 | 21,600 | — | $0 | 21,600 | SEC↗ |
| Leschly Nick | Director | A Award deriv | 2023-06-16 | 2023-06-20 | 21,600 | — | $0 | 21,600 | SEC↗ |
| Leiderman Elisabeth | Director | A Award deriv | 2023-06-16 | 2023-06-20 | 21,600 | — | $0 | 21,600 | SEC↗ |
| Vachon Mark | Director | A Award deriv | 2023-06-16 | 2023-06-20 | 21,600 | — | $0 | 21,600 | SEC↗ |
| Agwunobi John O | Director | A Award deriv | 2023-06-16 | 2023-06-20 | 21,600 | — | $0 | 21,600 | SEC↗ |
| Tita-Reid Najoh | Director | A Award deriv | 2023-06-16 | 2023-06-20 | 21,600 | — | $0 | 21,600 | SEC↗ |
| Jones-Burton Charlotte | Director | A Award | 2023-06-16 | 2023-06-20 | 10,790 | — | $0 | 18,562 | SEC↗ |
| Leschly Nick | Director | A Award | 2023-06-16 | 2023-06-20 | 10,790 | — | $0 | 290,939 | SEC↗ |
| Leiderman Elisabeth | Director | A Award | 2023-06-16 | 2023-06-20 | 10,790 | — | $0 | 22,256 | SEC↗ |
| Vachon Mark | Director | A Award | 2023-06-16 | 2023-06-20 | 10,790 | — | $0 | 25,041 | SEC↗ |
| Agwunobi John O | Director | A Award | 2023-06-16 | 2023-06-20 | 10,790 | — | $0 | 26,464 | SEC↗ |
| Tita-Reid Najoh | Director | A Award | 2023-06-16 | 2023-06-20 | 10,790 | — | $0 | 23,260 | SEC↗ |
| Klima Thomas J | See Remarks | S Sale | 2023-06-02 | 2023-06-06 | 4,130 | $3.50 | $14.5K | 133,049 | SEC↗ |
| Paulson Richard A. | Director | A Award deriv | 2023-04-03 | 2023-04-05 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Paulson Richard A. | Director | A Award | 2023-04-03 | 2023-04-05 | 4,663 | — | $0 | 4,663 | SEC↗ |
| Obenshain Andrew | President and CEO | A Award deriv | 2023-03-01 | 2023-03-03 | 338,000 | — | $0 | 338,000 | SEC↗ |
| Klima Thomas J | See Remarks | A Award deriv | 2023-03-01 | 2023-03-03 | 110,000 | — | $0 | 110,000 | SEC↗ |
| Colvin Richard A | Chief Medical Officer | A Award deriv | 2023-03-01 | 2023-03-03 | 110,000 | — | $0 | 110,000 | SEC↗ |
| Obenshain Andrew | President and CEO | A Award | 2023-03-01 | 2023-03-03 | 67,600 | — | $0 | 308,870 | SEC↗ |
| Klima Thomas J | See Remarks | A Award | 2023-03-01 | 2023-03-03 | 55,000 | — | $0 | 137,179 | SEC↗ |
| Colvin Richard A | Chief Medical Officer | A Award | 2023-03-01 | 2023-03-03 | 55,000 | — | $0 | 128,078 | SEC↗ |
| Vittiglio Joseph | Chief Business & Legal Offic | A Award deriv | 2023-02-01 | 2023-02-03 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Vittiglio Joseph | Chief Business & Legal Offic | A Award | 2023-02-01 | 2023-02-03 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Obenshain Andrew | President and CEO | F Tax w/h | 2023-02-01 | 2023-02-03 | 1,420 | $6.38 | $9.1K | 241,270 | SEC↗ |
| Colvin Richard A | Chief Medical Officer | F Tax w/h | 2023-02-01 | 2023-02-03 | 1,153 | $6.38 | $7.4K | 73,078 | SEC↗ |
| Klima Thomas J | See Remarks | F Tax w/h | 2023-02-01 | 2023-02-03 | 2,260 | $6.38 | $14.4K | 82,179 | SEC↗ |
| Leschly Nick | Director | S Sale | 2023-01-11 | 2023-01-13 | 4,290 | $7.80 | $33.5K | 280,149 | SEC↗ |
| Colvin Richard A | Chief Medical Officer | S Sale | 2023-01-11 | 2023-01-13 | 557 | $7.80 | $4.3K | 74,231 | SEC↗ |
| Obenshain Andrew | President and CEO | S Sale | 2023-01-11 | 2023-01-13 | 3,178 | $7.80 | $24.8K | 242,690 | SEC↗ |
| Krawtschuk Christopher | Chief Financial Officer | A Award deriv | 2022-12-01 | 2022-12-05 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Krawtschuk Christopher | Chief Financial Officer | A Award | 2022-12-01 | 2022-12-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Obenshain Andrew | President and CEO | S Sale | 2022-11-04 | 2022-11-08 | 1,263 | $6.41 | $8.1K | 245,868 | SEC↗ |
| Colvin Richard A | Chief Medical Officer | S Sale | 2022-11-04 | 2022-11-08 | 218 | $6.41 | $1.4K | 74,788 | SEC↗ |
| Colvin Richard A | Chief Medical Officer | A Award deriv | 2022-11-01 | 2022-11-03 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Colvin Richard A | Chief Medical Officer | A Award | 2022-11-01 | 2022-11-03 | 30,000 | — | $0 | 75,006 | SEC↗ |
| Leiderman Elisabeth | Director | S Sale | 2022-10-17 | 2023-03-09 | 1,004 | $6.46 | $6.5K | 11,466 | SEC↗ |
| Klima Thomas J | See Remarks | A Award deriv | 2022-09-01 | 2022-09-06 | 22,000 | — | $0 | 22,000 | SEC↗ |
| Klima Thomas J | See Remarks | A Award | 2022-09-01 | 2022-09-06 | 11,000 | — | $0 | 82,439 | SEC↗ |
| Cole Jason | Chief Strategy & Financial O | S Sale | 2022-08-19 | 2022-08-23 | 14,194 | $5.53 | $78.5K | 189,546 | SEC↗ |
| Cole Jason | Chief Strategy & Financial O | S Sale | 2022-08-04 | 2022-08-08 | 7,448 | $4.39 | $32.7K | 203,740 | SEC↗ |
| Obenshain Andrew | President and CEO | S Sale | 2022-08-04 | 2022-08-08 | 21,805 | $4.39 | $95.7K | 247,131 | SEC↗ |
| Eggimann Anne-Virginie | Chief Regulatory Officer | S Sale | 2022-07-12 | 2022-07-14 | 1,358 | $4.95 | $6.7K | 42,252 | SEC↗ |
| Tita-Reid Najoh | Director | A Award deriv | 2022-06-22 | 2022-06-23 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Leiderman Elisabeth | Director | A Award deriv | 2022-06-22 | 2022-06-23 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Agwunobi John O | Director | A Award deriv | 2022-06-22 | 2022-06-23 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Vachon Mark | Director | A Award deriv | 2022-06-22 | 2022-06-23 | 7,000 | — | $0 | 7,000 | SEC↗ |
| Leschly Nick | Director | A Award deriv | 2022-06-22 | 2022-06-23 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Jones-Burton Charlotte | Director | A Award deriv | 2022-06-22 | 2022-06-23 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Tita-Reid Najoh | Director | A Award | 2022-06-22 | 2022-06-23 | 3,109 | — | $0 | 12,470 | SEC↗ |
| Leiderman Elisabeth | Director | A Award | 2022-06-22 | 2022-06-23 | 3,109 | — | $0 | 12,470 | SEC↗ |
| Agwunobi John O | Director | A Award | 2022-06-22 | 2022-06-23 | 3,109 | — | $0 | 15,674 | SEC↗ |
| Vachon Mark | Director | A Award | 2022-06-22 | 2022-06-23 | 4,353 | — | $0 | 14,251 | SEC↗ |
| Leschly Nick | Director | A Award | 2022-06-22 | 2022-06-23 | 3,109 | — | $0 | 284,439 | SEC↗ |
| Jones-Burton Charlotte | Director | A Award | 2022-06-22 | 2022-06-23 | 3,109 | — | $0 | 7,772 | SEC↗ |
| Klima Thomas J | Chief Commercial Officer | S Sale | 2022-06-03 | 2022-06-07 | 3,753 | $3.07 | $11.5K | 71,439 | SEC↗ |
| Jones-Burton Charlotte | Director | A Award deriv | 2022-03-07 | 2022-03-09 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Jones-Burton Charlotte | Director | A Award | 2022-03-07 | 2022-03-09 | 4,663 | — | $0 | 4,663 | SEC↗ |
| Cole Jason | Chief Business Officer | A Award deriv | 2022-02-01 | 2022-02-03 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Klima Thomas J | Chief Commercial Officer | A Award deriv | 2022-02-01 | 2022-02-03 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Consylman Gina | Chief Financial Officer | A Award deriv | 2022-02-01 | 2022-02-03 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Whitten Jessica | Chief Accounting Officer | A Award deriv | 2022-02-01 | 2022-02-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Eggimann Anne-Virginie | Chief Regulatory Officer | A Award deriv | 2022-02-01 | 2022-02-03 | 34,000 | — | $0 | 34,000 | SEC↗ |
| Obenshain Andrew | President and CEO | A Award deriv | 2022-02-01 | 2022-02-03 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Cole Jason | Chief Business Officer | A Award | 2022-02-01 | 2022-02-03 | 25,000 | — | $0 | 211,188 | SEC↗ |
| Klima Thomas J | Chief Commercial Officer | A Award | 2022-02-01 | 2022-02-03 | 25,000 | — | $0 | 75,192 | SEC↗ |
| Consylman Gina | Chief Financial Officer | A Award | 2022-02-01 | 2022-02-03 | 25,000 | — | $0 | 125,385 | SEC↗ |
| Whitten Jessica | Chief Accounting Officer | A Award | 2022-02-01 | 2022-02-03 | 7,500 | — | $0 | 56,913 | SEC↗ |
| Eggimann Anne-Virginie | Chief Regulatory Officer | A Award | 2022-02-01 | 2022-02-03 | 17,000 | — | $0 | 43,610 | SEC↗ |
| Obenshain Andrew | President and CEO | A Award | 2022-02-01 | 2022-02-03 | 18,000 | — | $0 | 268,936 | SEC↗ |
| Obenshain Andrew | President and CEO | S Sale | 2022-01-11 | 2022-01-12 | 4,683 | $9.64 | $45.1K | 246,696 | SEC↗ |
| Leschly Nick | Director | S Sale | 2022-01-11 | 2022-01-12 | 5,068 | $9.64 | $48.9K | 281,330 | SEC↗ |
| Cole Jason | Chief Operating and | S Sale | 2022-01-11 | 2022-01-12 | 3,387 | $9.64 | $32.7K | 186,188 | SEC↗ |
| Whitten Jessica | Chief Accounting Officer | S Sale | 2022-01-11 | 2022-01-12 | 279 | $9.64 | $2.7K | 49,413 | SEC↗ |
| Obenshain Andrew | President and CEO | S Sale | 2022-01-10 | 2022-01-12 | 852 | $9.24 | $7.9K | 253,569 | SEC↗ |
| Obenshain Andrew | President and CEO | S Sale | 2022-01-10 | 2022-01-12 | 2,190 | $9.40 | $20.6K | 251,379 | SEC↗ |
| Leschly Nick | Director | S Sale | 2022-01-10 | 2022-01-12 | 2,369 | $9.40 | $22.3K | 286,398 | SEC↗ |
| Cole Jason | Chief Operating and | S Sale | 2022-01-10 | 2022-01-12 | 1,584 | $9.40 | $14.9K | 189,575 | SEC↗ |
| Whitten Jessica | Chief Accounting Officer | S Sale | 2022-01-10 | 2022-01-12 | 130 | $9.40 | $1.2K | 49,692 | SEC↗ |
| Whitten Jessica | Chief Accounting Officer | S Sale | 2022-01-05 | 2022-01-07 | 2,984 | $10.44 | $31.2K | 49,822 | SEC↗ |
| Whitten Jessica | Chief Accounting Officer | A Award | 2021-12-22 | 2021-12-27 | 9,502 | — | $0 | 52,806 | SEC↗ |
| Obenshain Andrew | President and CEO | S Sale | 2021-12-07 | 2021-12-09 | 832 | $10.18 | $8.5K | 254,421 | SEC↗ |
| Vachon Mark | Director | J Other deriv | 2021-11-11 | 2021-11-16 | 2,953 | — | $0 | 2,953 | SEC↗ |
| Vachon Mark | Director | J Other deriv | 2021-11-11 | 2021-11-16 | 10,038 | — | $0 | 10,038 | SEC↗ |
| Vachon Mark | Director | J Other deriv | 2021-11-11 | 2021-11-16 | 7,384 | — | $0 | 7,384 | SEC↗ |
| Vachon Mark | Director | J Other deriv | 2021-11-11 | 2021-11-16 | 3,938 | — | $0 | 3,938 | SEC↗ |
| Vachon Mark | Director | J Other deriv | 2021-11-11 | 2021-11-16 | 3,938 | — | $0 | 3,938 | SEC↗ |
| Vachon Mark | Director | J Other deriv | 2021-11-11 | 2021-11-16 | 3,938 | — | $0 | 3,938 | SEC↗ |
| Agwunobi John O | Director | J Other deriv | 2021-11-11 | 2021-11-16 | 3,938 | — | $0 | 3,938 | SEC↗ |
| Agwunobi John O | Director | J Other deriv | 2021-11-11 | 2021-11-16 | 10,534 | — | $0 | 10,534 | SEC↗ |
| Agwunobi John O | Director | J Other deriv | 2021-11-11 | 2021-11-16 | 3,938 | — | $0 | 3,938 | SEC↗ |
| Agwunobi John O | Director | J Other deriv | 2021-11-11 | 2021-11-16 | 10,038 | — | $0 | 10,038 | SEC↗ |
| Agwunobi John O | Director | J Other deriv | 2021-11-11 | 2021-11-16 | 3,938 | — | $0 | 3,938 | SEC↗ |
| Leiderman Elisabeth | Director | D To issuer deriv | 2021-11-11 | 2021-11-16 | 15,057 | — | $0 | 15,057 | SEC↗ |
| Tita-Reid Najoh | Director | J Other deriv | 2021-11-11 | 2021-11-16 | 15,057 | — | $0 | 15,057 | SEC↗ |
| Consylman Gina | Chief Financial Officer | J Other deriv | 2021-11-11 | 2021-11-16 | 170,655 | — | $0 | 170,655 | SEC↗ |
| Whitten Jessica | Chief Accounting Officer | J Other deriv | 2021-11-11 | 2021-11-16 | 8,030 | — | $0 | 8,030 | SEC↗ |
| Whitten Jessica | Chief Accounting Officer | J Other deriv | 2021-11-11 | 2021-11-16 | 7,776 | — | $0 | 7,776 | SEC↗ |
| Klima Thomas J | Chief Commercial Officer | D To issuer deriv | 2021-11-11 | 2021-11-16 | 100,385 | — | $0 | 100,385 | SEC↗ |
| Torres Denice | Director | D To issuer deriv | 2021-11-11 | 2021-11-17 | 4,500 | — | $0 | 4,430 | SEC↗ |
| Torres Denice | Director | D To issuer deriv | 2021-11-11 | 2021-11-17 | 5,000 | — | $0 | 0 | SEC↗ |
| Obenshain Andrew | Chief Executive Officer | J Other deriv | 2021-11-11 | 2021-11-17 | 30,000 | — | $0 | 60,230 | SEC↗ |
| Obenshain Andrew | Chief Executive Officer | J Other deriv | 2021-11-11 | 2021-11-17 | 200,000 | — | $0 | 401,543 | SEC↗ |
| Obenshain Andrew | Chief Executive Officer | J Other deriv | 2021-11-11 | 2021-11-17 | 18,000 | — | $0 | 17,721 | SEC↗ |
| Obenshain Andrew | Chief Executive Officer | J Other deriv | 2021-11-11 | 2021-11-17 | 9,500 | — | $0 | 9,353 | SEC↗ |
| Obenshain Andrew | Chief Executive Officer | J Other deriv | 2021-11-11 | 2021-11-17 | 7,950 | — | $0 | 7,827 | SEC↗ |
| Obenshain Andrew | Chief Executive Officer | J Other deriv | 2021-11-11 | 2021-11-17 | 21,000 | — | $0 | 20,674 | SEC↗ |
| Obenshain Andrew | Chief Executive Officer | J Other deriv | 2021-11-11 | 2021-11-17 | 7,000 | — | $0 | 6,891 | SEC↗ |
| Baird William D III | Chief Financial Officer | J Other deriv | 2021-11-11 | 2021-11-17 | 60,000 | — | $0 | 59,072 | SEC↗ |
| Baird William D III | Chief Financial Officer | J Other deriv | 2021-11-11 | 2021-11-17 | 20,000 | — | $0 | 19,690 | SEC↗ |
| Baird William D III | Chief Financial Officer | J Other deriv | 2021-11-11 | 2021-11-17 | 25,000 | — | $0 | 0 | SEC↗ |
| Glickman Sarah JS | Director | J Other deriv | 2021-11-11 | 2021-11-17 | 7,500 | — | $0 | 0 | SEC↗ |
| Ibrahim Ramy | Director | J Other deriv | 2021-11-11 | 2021-11-17 | 5,000 | — | $0 | 0 | SEC↗ |
| Ibrahim Ramy | Director | J Other deriv | 2021-11-11 | 2021-11-17 | 4,500 | — | $0 | 0 | SEC↗ |
| Leschly Nick | Director | D To issuer deriv | 2021-11-11 | 2021-11-17 | 100,000 | — | $0 | 98,454 | SEC↗ |
| Leschly Nick | Director | D To issuer deriv | 2021-11-11 | 2021-11-17 | 65,000 | — | $0 | 63,995 | SEC↗ |
| Leschly Nick | Director | D To issuer deriv | 2021-11-11 | 2021-11-17 | 90,000 | — | $0 | 0 | SEC↗ |
| Leschly Nick | Director | D To issuer deriv | 2021-11-11 | 2021-11-17 | 120,000 | — | $0 | 118,145 | SEC↗ |
| Leschly Nick | Director | D To issuer deriv | 2021-11-11 | 2021-11-17 | 90,000 | — | $0 | 88,609 | SEC↗ |
| Leschly Nick | Director | D To issuer deriv | 2021-11-11 | 2021-11-17 | 110,000 | — | $0 | 108,300 | SEC↗ |
| Leschly Nick | Director | D To issuer deriv | 2021-11-11 | 2021-11-17 | 165,000 | — | $0 | 162,450 | SEC↗ |
| Leschly Nick | Director | D To issuer deriv | 2021-11-11 | 2021-11-17 | 165,000 | — | $0 | 162,450 | SEC↗ |
| LYNCH DANIEL | Director | J Other deriv | 2021-11-11 | 2021-11-17 | 7,000 | — | $0 | 0 | SEC↗ |
| LYNCH DANIEL | Director | J Other deriv | 2021-11-11 | 2021-11-17 | 4,200 | — | $0 | 4,135 | SEC↗ |
| LYNCH DANIEL | Director | J Other deriv | 2021-11-11 | 2021-11-17 | 23,342 | — | $0 | 22,981 | SEC↗ |
| LYNCH DANIEL | Director | J Other deriv | 2021-11-11 | 2021-11-17 | 10,500 | — | $0 | 10,337 | SEC↗ |
| LYNCH DANIEL | Director | J Other deriv | 2021-11-11 | 2021-11-17 | 10,500 | — | $0 | 10,337 | SEC↗ |
| LYNCH DANIEL | Director | J Other deriv | 2021-11-11 | 2021-11-17 | 5,600 | — | $0 | 5,513 | SEC↗ |
| LYNCH DANIEL | Director | J Other deriv | 2021-11-11 | 2021-11-17 | 5,600 | — | $0 | 5,513 | SEC↗ |
| LYNCH DANIEL | Director | J Other deriv | 2021-11-11 | 2021-11-17 | 5,600 | — | $0 | 5,513 | SEC↗ |
| LYNCH DANIEL | Director | J Other deriv | 2021-11-11 | 2021-11-17 | 5,600 | — | $0 | 5,513 | SEC↗ |
| DIXON WENDY L | Director | J Other deriv | 2021-11-11 | 2021-11-17 | 5,000 | — | $0 | 10,038 | SEC↗ |
| DIXON WENDY L | Director | J Other deriv | 2021-11-11 | 2021-11-17 | 4,000 | — | $0 | 3,938 | SEC↗ |
| DIXON WENDY L | Director | J Other deriv | 2021-11-11 | 2021-11-17 | 4,000 | — | $0 | 3,938 | SEC↗ |
| DIXON WENDY L | Director | J Other deriv | 2021-11-11 | 2021-11-17 | 7,500 | — | $0 | 7,384 | SEC↗ |
| DIXON WENDY L | Director | J Other deriv | 2021-11-11 | 2021-11-17 | 7,500 | — | $0 | 7,384 | SEC↗ |
| DIXON WENDY L | Director | J Other deriv | 2021-11-11 | 2021-11-17 | 26,361 | — | $0 | 25,953 | SEC↗ |
| DIXON WENDY L | Director | J Other deriv | 2021-11-11 | 2021-11-17 | 3,000 | — | $0 | 2,953 | SEC↗ |
| DIXON WENDY L | Director | J Other deriv | 2021-11-11 | 2021-11-17 | 4,000 | — | $0 | 3,938 | SEC↗ |
| DIXON WENDY L | Director | J Other deriv | 2021-11-11 | 2021-11-17 | 4,000 | — | $0 | 3,938 | SEC↗ |
| Maus Marcela V. | Director | J Other deriv | 2021-11-11 | 2021-11-17 | 7,500 | — | $0 | 0 | SEC↗ |
| Cole Jason | Chief Business Officer | J Other deriv | 2021-11-11 | 2021-11-17 | 8,938 | — | $0 | 8,799 | SEC↗ |
| Cole Jason | Chief Business Officer | J Other deriv | 2021-11-11 | 2021-11-17 | 28,500 | — | $0 | 28,059 | SEC↗ |
| Cole Jason | Chief Business Officer | J Other deriv | 2021-11-11 | 2021-11-17 | 25,000 | — | $0 | 24,613 | SEC↗ |
| Cole Jason | Chief Business Officer | J Other deriv | 2021-11-11 | 2021-11-17 | 25,000 | — | $0 | 24,613 | SEC↗ |
| Cole Jason | Chief Business Officer | J Other deriv | 2021-11-11 | 2021-11-17 | 18,000 | — | $0 | 17,721 | SEC↗ |
| Cole Jason | Chief Business Officer | J Other deriv | 2021-11-11 | 2021-11-17 | 35,000 | — | $0 | 34,458 | SEC↗ |
| Cole Jason | Chief Business Officer | J Other deriv | 2021-11-11 | 2021-11-17 | 27,500 | — | $0 | 55,211 | SEC↗ |
| Gregory Philip D | Chief Scientific Officer | J Other deriv | 2021-11-11 | 2021-11-17 | 27,000 | — | $0 | 26,582 | SEC↗ |
| Gregory Philip D | Chief Scientific Officer | J Other deriv | 2021-11-11 | 2021-11-17 | 50,000 | — | $0 | 49,227 | SEC↗ |
| Gregory Philip D | Chief Scientific Officer | J Other deriv | 2021-11-11 | 2021-11-17 | 6,200 | — | $0 | 6,103 | SEC↗ |
| Gregory Philip D | Chief Scientific Officer | J Other deriv | 2021-11-11 | 2021-11-17 | 25,000 | — | $0 | 24,613 | SEC↗ |
| Gregory Philip D | Chief Scientific Officer | J Other deriv | 2021-11-11 | 2021-11-17 | 25,000 | — | $0 | 0 | SEC↗ |
| Gregory Philip D | Chief Scientific Officer | J Other deriv | 2021-11-11 | 2021-11-17 | 20,000 | — | $0 | 19,690 | SEC↗ |
| Gregory Philip D | Chief Scientific Officer | J Other deriv | 2021-11-11 | 2021-11-17 | 34,000 | — | $0 | 33,474 | SEC↗ |
| Sellers William R. | Director | D To issuer deriv | 2021-11-11 | 2021-11-17 | 5,000 | — | $0 | 0 | SEC↗ |
| Sellers William R. | Director | D To issuer deriv | 2021-11-11 | 2021-11-17 | 8,000 | — | $0 | 7,876 | SEC↗ |
| Sellers William R. | Director | D To issuer deriv | 2021-11-11 | 2021-11-17 | 3,000 | — | $0 | 2,953 | SEC↗ |
| Vachon Mark | Director | J Other | 2021-11-11 | 2021-11-16 | 6,241 | — | $0 | 9,898 | SEC↗ |
| Agwunobi John O | Director | J Other | 2021-11-11 | 2021-11-16 | 6,241 | — | $0 | 12,565 | SEC↗ |
| Leiderman Elisabeth | Director | J Other | 2021-11-11 | 2021-11-16 | 9,361 | — | $0 | 9,361 | SEC↗ |
| Tita-Reid Najoh | Director | J Other | 2021-11-11 | 2021-11-16 | 9,361 | — | $0 | 9,361 | SEC↗ |
| Consylman Gina | Chief Financial Officer | J Other | 2021-11-11 | 2021-11-16 | 100,385 | — | $0 | 100,385 | SEC↗ |
| Whitten Jessica | Chief Accounting Officer | J Other | 2021-11-11 | 2021-11-16 | 36,931 | — | $0 | 43,304 | SEC↗ |
| Whitten Jessica | Chief Accounting Officer | J Other | 2021-11-11 | 2021-11-16 | 1,459 | — | $0 | 2,358 | SEC↗ |
| Whitten Jessica | Chief Accounting Officer | J Other | 2021-11-11 | 2021-11-16 | 4,015 | — | $0 | 6,373 | SEC↗ |
| Klima Thomas J | Chief Commercial Officer | J Other | 2021-11-11 | 2021-11-16 | 50,192 | — | $0 | 50,192 | SEC↗ |
| Torres Denice | Director | J Other | 2021-11-11 | 2021-11-17 | 0 | — | $0 | 2,726 | SEC↗ |
| Torres Denice | Director | J Other | 2021-11-11 | 2021-11-17 | 1,476 | — | $0 | 2,726 | SEC↗ |
| Obenshain Andrew | Chief Executive Officer | J Other | 2021-11-11 | 2021-11-17 | 978 | — | $0 | 11,446 | SEC↗ |
| Obenshain Andrew | Chief Executive Officer | J Other | 2021-11-11 | 2021-11-17 | 200,771 | — | $0 | 255,253 | SEC↗ |
| Obenshain Andrew | Chief Executive Officer | J Other | 2021-11-11 | 2021-11-17 | 30,115 | — | $0 | 54,482 | SEC↗ |
| Obenshain Andrew | Chief Executive Officer | J Other | 2021-11-11 | 2021-11-17 | 2,584 | — | $0 | 14,030 | SEC↗ |
| Obenshain Andrew | Chief Executive Officer | J Other | 2021-11-11 | 2021-11-17 | 10,337 | — | $0 | 24,367 | SEC↗ |
| Obenshain Andrew | Chief Executive Officer | J Other | 2021-11-11 | 2021-11-17 | 586 | — | $0 | 10,468 | SEC↗ |
| Baird William D III | Chief Financial Officer | J Other | 2021-11-11 | 2021-11-17 | 0 | — | $0 | 22,797 | SEC↗ |
| Baird William D III | Chief Financial Officer | J Other | 2021-11-11 | 2021-11-17 | 0 | — | $0 | 22,797 | SEC↗ |
| Baird William D III | Chief Financial Officer | J Other | 2021-11-11 | 2021-11-17 | 7,384 | — | $0 | 22,797 | SEC↗ |
| Baird William D III | Chief Financial Officer | J Other | 2021-11-11 | 2021-11-17 | 7,384 | — | $0 | 15,413 | SEC↗ |
| Baird William D III | Chief Financial Officer | J Other | 2021-11-11 | 2021-11-17 | 0 | — | $0 | 22,797 | SEC↗ |
| Glickman Sarah JS | Director | J Other | 2021-11-11 | 2021-11-17 | 0 | — | $0 | 0 | SEC↗ |
| Ibrahim Ramy | Director | J Other | 2021-11-11 | 2021-11-17 | 0 | — | $0 | 0 | SEC↗ |
| Ibrahim Ramy | Director | J Other | 2021-11-11 | 2021-11-17 | 0 | — | $0 | 0 | SEC↗ |
| Leschly Nick | Director | J Other | 2021-11-11 | 2021-11-17 | 7,384 | — | $0 | 251,701 | SEC↗ |
| Leschly Nick | Director | J Other | 2021-11-11 | 2021-11-17 | 12,306 | — | $0 | 264,007 | SEC↗ |
| Leschly Nick | Director | J Other | 2021-11-11 | 2021-11-17 | 23,998 | — | $0 | 288,005 | SEC↗ |
| Leschly Nick | Director | J Other | 2021-11-11 | 2021-11-17 | 0 | — | $0 | 288,005 | SEC↗ |
| Leschly Nick | Director | J Other | 2021-11-11 | 2021-11-17 | 0 | — | $0 | 288,005 | SEC↗ |
| Leschly Nick | Director | J Other | 2021-11-11 | 2021-11-17 | 0 | — | $0 | 288,005 | SEC↗ |
| Leschly Nick | Director | J Other | 2021-11-11 | 2021-11-17 | 0 | — | $0 | 288,767 | SEC↗ |
| LYNCH DANIEL | Director | J Other | 2021-11-11 | 2021-11-17 | 0 | — | $0 | 7,959 | SEC↗ |
| DIXON WENDY L | Director | J Other | 2021-11-11 | 2021-11-17 | 6,241 | — | $0 | 11,894 | SEC↗ |
| Maus Marcela V. | Director | J Other | 2021-11-11 | 2021-11-17 | 0 | — | $0 | 0 | SEC↗ |
| Cole Jason | Chief Business Officer | J Other | 2021-11-11 | 2021-11-17 | 3,077 | — | $0 | 27,348 | SEC↗ |
| Cole Jason | Chief Business Officer | J Other | 2021-11-11 | 2021-11-17 | 6,645 | — | $0 | 33,993 | SEC↗ |
| Cole Jason | Chief Business Officer | J Other | 2021-11-11 | 2021-11-17 | 27,606 | — | $0 | 61,599 | SEC↗ |
| Cole Jason | Chief Business Officer | J Other | 2021-11-11 | 2021-11-17 | 64,781 | — | $0 | 126,380 | SEC↗ |
| Cole Jason | Chief Business Officer | J Other | 2021-11-11 | 2021-11-17 | 64,779 | — | $0 | 191,159 | SEC↗ |
| Cole Jason | Chief Business Officer | J Other | 2021-11-11 | 2021-11-17 | 1,539 | — | $0 | 24,271 | SEC↗ |
| Gregory Philip D | Chief Scientific Officer | J Other | 2021-11-11 | 2021-11-17 | 0 | — | $0 | 34,127 | SEC↗ |
| Gregory Philip D | Chief Scientific Officer | J Other | 2021-11-11 | 2021-11-17 | 0 | — | $0 | 34,127 | SEC↗ |
| Gregory Philip D | Chief Scientific Officer | J Other | 2021-11-11 | 2021-11-17 | 2,092 | — | $0 | 23,420 | SEC↗ |
| Gregory Philip D | Chief Scientific Officer | J Other | 2021-11-11 | 2021-11-17 | 3,323 | — | $0 | 26,743 | SEC↗ |
| Gregory Philip D | Chief Scientific Officer | J Other | 2021-11-11 | 2021-11-17 | 0 | — | $0 | 34,127 | SEC↗ |
| Gregory Philip D | Chief Scientific Officer | J Other | 2021-11-11 | 2021-11-17 | 7,384 | — | $0 | 34,127 | SEC↗ |
| Sellers William R. | Director | J Other | 2021-11-11 | 2021-11-17 | 657 | — | $0 | 3,601 | SEC↗ |
| Sellers William R. | Director | J Other | 2021-11-11 | 2021-11-17 | 0 | — | $0 | 3,601 | SEC↗ |
| Leiderman Elisabeth | Director | A Award deriv | 2021-10-15 | 2021-10-19 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Leiderman Elisabeth | Director | A Award | 2021-10-15 | 2021-10-19 | 4,663 | — | $0 | 4,663 | SEC↗ |
| Tita-Reid Najoh | Director | A Award deriv | 2021-09-29 | 2021-10-01 | 7,500 | — | $0 | 7,500 | SEC↗ |